Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.01 (-1.00%)
Close on Nov 13, 2026Market cap $18.88MP/E –Yield –
Cocrystal Pharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cocrystal Pharma's ebitda for the twelve months ending Jun 30, 2026 was -$10.06M. For fiscal 2025 it was -$8.95M. The highest annual figure on record is $400.52K in fiscal 2010.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.95M | – |
| FY2024 | Dec 31, 2024 | -$17.75M | – |
| FY2023 | Dec 31, 2023 | -$18.37M | – |
| FY2022 | Dec 31, 2022 | -$38.64M | – |
| FY2021 | Dec 31, 2021 | -$14.03M | – |
| FY2020 | Dec 31, 2020 | -$9.43M | – |
| FY2019 | Dec 31, 2019 | -$48.31M | – |
| FY2018 | Dec 31, 2018 | -$62.87M | – |
| FY2017 | Dec 31, 2017 | -$8.16M | – |
| FY2016 | Dec 31, 2016 | -$105.62M | – |
| FY2015 | Dec 31, 2015 | -$53.76M | – |
| FY2014 | Dec 31, 2014 | -$5.60M | – |
| FY2013 | Dec 31, 2013 | -$3.85M | – |
| FY2012 | Dec 31, 2012 | -$2.41M | – |
| FY2011 | Dec 31, 2011 | -$3.36M | -937.7% |
| FY2010 | Dec 31, 2010 | $400.52K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.34M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.47M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.08M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.32M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.20M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.42M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.63M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$24.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.16M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.65M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.91M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.78M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.93M | -166.6% |
| Q4 FY2019 | Dec 31, 2019 | -$47.90M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.78M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.53M | – |
| Q1 FY2019 | Mar 31, 2019 | $2.90M | – |
| Q4 FY2018 | Dec 31, 2018 | -$56.29M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.41M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.09M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.08M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.10M | – |
| Q4 FY2016 | Dec 31, 2016 | -$94.34M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.84M | – |
See a number that looks wrong?